The SneakPeek® Early Gender Test was previously shown to be 99.9% accurate in determining fetal sex as early as seven weeks of gestation. To our knowledge, no prior study has shown fetal sex identification from maternal plasma earlier than seven weeks of gestation with high accuracy. The SneakPeek assay was further optimized to enable fetal sex identification at earlier gestations and its performance characteristics were determined at 6-weeks’ gestation.

COVID-19 testing has become a cornerstone in the ongoing effort to manage and mitigate the impact of the global pandemic caused by the novel coronavirus. This exploration delves into the intricacies of COVID-19 testing, highlighting its pivotal role for individuals and communities seeking clarity on their health status in the face of the pandemic.

Drug testing serves as a vital element in maintaining safety and promoting wellness, addressing concerns related to substance use and ensuring a secure environment. This exploration delves into the intricacies of drug testing, highlighting its pivotal role for individuals and organizations seeking to uphold a drug-free and healthy community